Clinical Trial

A Study of Tris-Hydroxymethyl Aminomethane (THAM) Versus Sodium Bicarbonate in Cardiac Surgical Patients

Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The purpose of this research is to determine if two commonly used medications to treat metabolic acidosis in the setting of cardiac surgery, sodium bicarbonate and THAM, are equivalent.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2027-02 -> 2027-12 2026-08-04
minor Completion pushed: 2027-08 -> 2028-06 2026-08-04
Trial Details
NCT Number NCT07424625
Lead Sponsor Mayo Clinic
Conditions Metabolic Acidosis
Enrollment 250 participants
Start Date 2026-09
Primary Completion 2027-12 (estimated)
Study Completion 2028-06 (estimated)
Updated on ClinicalTrials.gov 2026-08-03